Payments to Acquire Property, Plant, and Equipment of Monte Rosa Therapeutics, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Monte Rosa Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Monte Rosa Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $1,587,000, a 15% increase year-over-year.
  • Monte Rosa Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $4,700,000, a 18% increase from 2024.
  • Monte Rosa Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $3,988,000, a 79% decline from 2023.
  • Monte Rosa Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $19,041,000, a 47% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Monte Rosa Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $4,700,000 +$712,000 +18% 01 Jan 2025 31 Dec 2025 10-K 17 Mar 2026 2025 FY
2024 $3,988,000 -$15,053,000 -79% 01 Jan 2024 31 Dec 2024 10-K 17 Mar 2026 2025 FY
2023 $19,041,000 +$6,130,000 +47% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 $12,911,000 +$3,179,000 +33% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $9,732,000 +$6,343,000 +187% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $3,389,000 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY

Monte Rosa Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,587,000 +$203,000 +15% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $1,384,000 -$7,797,000 -85% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $9,181,000 +$7,494,000 +444% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $1,687,000 -$530,000 -24% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $2,217,000 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.